Drone Maker Sees Business Opportunity In Keeping Workers And Warfighters Safe (Forbes)
This is the story of UF startup Altavian’s beginnings and a little hint of the role UF Innovate | Tech Licensing played in it. For intrepid wildlife biologists stomping around in the bush, it’s not an animal mauling or an attacking microbe that most often spells doom. Statistically speaking, it’s the aircraft they use to […]
Entrinsic Health Solutions and Nestlé Health Science Enter Global Partnership for Novel Amino Acid Product enterade® (BusinessWire)
UF startup Entrinsic Health Solutions (EHS), an innovative health sciences company, announced that they have entered into a partnership with Nestlé Health Science (NHSc), a global innovative leader pioneering premium-quality, science-based nutritional health solutions. The partnership gives NHSc the exclusive rights to market EHS’s enterade® product. This partnership is structured as a worldwide commercial license […]
UF Innovate | The Hub Resident Client aha Pure Foods Wins Cox Business’ Get Started Gainesville Business Pitch Competition (BusinessWire)
UF Innovate | The Hub, a leading business incubator in the University of Florida business incubation system, announced that resident client aha Pure Foods, a vegan soup company, is the 2018 winner of the Cox Business’ Get Started Gainesville Business Pitch Competition. Cox Business selected five finalists out of more than 40 local business applicants […]
DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer (PR Newswire)
UF startup DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix’s clinical stage viruses and Valo’s proprietary antigenic peptide technology. DNAtrix’s clinical stage oncolytic adenovirus platform and Valo’s PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus) vaccination technology will be combined to generate a novel “armed oncolytic vaccine” for cancer therapy. While […]
Banyan Biomarkers Receives Contract by U.S. Department of Defense for Banyan BTI™ (BusinessWire)
UF startup Banyan Biomarkers, Inc., a pioneer in developing biomarkers for mild traumatic brain injury (TBI), has been awarded a contract by the U.S. Department of Defense (DOD) to procure the Banyan Brain Trauma Indicator® (Banyan BTI™). Banyan Biomarkers is a graduate of UF Innovate | Sid Martin Biotech. The Banyan BTI is a diagnostic […]
OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD (PR Newswire)
UF startup OxThera AB, a Stockholm-based privately-held biopharmaceutical company and leader in the field of microbiome derived biotherapeutics, announced a poster presentation showing encouraging Oxabact® efficacy and safety data from the long-term study OC5-OL-01, at the Annual Meeting of the American Society of Nephrology Kidney Week 2018 in San Diego. “We are pleased to present […]
ViewRay to Supply UK’s GenesisCare With Country’s First MRIdian Systems (DOTmed)
UF startup ViewRay Inc. is set to deliver the first of Great Britain’s MRIdian MR-guided radiotherapy systems as part of a new partnership between it and the cancer service provider, GenesisCare. Deployed within the GenesisCare network, the first two systems will offer oncologists the ability to leverage soft-tissue imaging for the visualization of tumors, personalizing […]
Sun BioPharma, Inc. to Present Results of New Pancreatitis Study at American Pancreatic Association Meeting in Miami Beach (Globe Newswire)
UF startup Sun BioPharma, Inc., a clinical stage biopharmaceutical company specializing in disruptive therapeutics for pancreatic diseases, announced that it will present results of a new study entitled “Effect of SBP-101 in a Mouse Model of Cerulein-induced Acute Pancreatitis” at the American Pancreatic Association meeting in Miami on Nov. 1. The study, performed in collaboration […]
Nash Pharmaceuticals Announces Positive Pre-Clinical Results Showing Lead Compound NP-160 Significantly Reduces NALFD Score and Fibrosis in Non-Alcoholic Fatty Liver Disease (Breathtec Biomedical)
Nash Pharmaceuticals Inc., a wholly owned subsidiary of UF startup Breathtec Biomedical Inc., is pleased to announce that its lead compound for non-alcoholic steatohepatitis (“NASH”) NP-160 showed positive results in a recently completed study investigating its therapeutic effects in the widely used STAM™ mouse model from SMC Laboratories. NP-160 is one of a number of […]
Breathtec Provides Update on FAIMS Breathalyzer Development Program (Globe Newswire)
UF startup Breathtec Biomedical Inc. is pleased to report on the development of its Breathtec Disease Detection Breathalyzer prototype (V3) based on the FAIMS (field asymmetric waveform ion mobility spectrometry) technology. The company announced that it has amended its research agreement with the University of Florida’s Analytical Chemistry Department, where Dr. Richard Yost, the principal […]